Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

European guidelines on managing adverse effects of medication for ADHD.

Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Döpfner M, Hamilton R, Hollis C, Holtmann M, Hulpke-Wette M, Lecendreux M, Rosenthal E, Rothenberger A, Santosh P, Sergeant J, Simonoff E, Sonuga-Barke E, Wong IC, Zuddas A, Steinhausen HC, Taylor E; European Guidelines Group.

Eur Child Adolesc Psychiatry. 2011 Jan;20(1):17-37. doi: 10.1007/s00787-010-0140-6. Epub 2010 Nov 3.

PMID:
21042924
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.

Santosh PJ, Sattar S, Canagaratnam M.

CNS Drugs. 2011 Sep 1;25(9):737-63. doi: 10.2165/11593070-000000000-00000. Review.

PMID:
21870887
[PubMed - indexed for MEDLINE]
3.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
[PubMed - indexed for MEDLINE]
4.

Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.

Graham J, Coghill D.

CNS Drugs. 2008;22(3):213-37. Review.

PMID:
18278977
[PubMed - indexed for MEDLINE]
5.

Pharmacologic treatment of ADHD: road conditions in driving patients to successful outcomes.

Manos MJ.

Medscape J Med. 2008 Jan 8;10(1):5. Review.

PMID:
18324315
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.

Cortese S, Holtmann M, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Graham J, Taylor E, Sergeant J; European ADHD Guidelines Group.

J Child Psychol Psychiatry. 2013 Mar;54(3):227-46. doi: 10.1111/jcpp.12036. Epub 2013 Jan 7. Review.

PMID:
23294014
[PubMed - indexed for MEDLINE]
7.

Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study.

Hennessy S, Schelleman H, Daniel GW, Bilker WB, Kimmel SE, Guevara J, Cziraky MJ, Strom BL.

Pharmacoepidemiol Drug Saf. 2010 Sep;19(9):934-41. doi: 10.1002/pds.1992.

PMID:
20623519
[PubMed - indexed for MEDLINE]
8.

ADHD update: new data on the risks of medication.

[No authors listed]

Harv Ment Health Lett. 2006 Oct;23(4):3-5. No abstract available.

PMID:
17183739
[PubMed - indexed for MEDLINE]
9.

Acute suicidality after commencing atomoxetine.

Paxton GA, Cranswick NE.

J Paediatr Child Health. 2008 Oct;44(10):596-8. doi: 10.1111/j.1440-1754.2008.01389.x.

PMID:
19012633
[PubMed - indexed for MEDLINE]
10.

Adult attention-deficit/hyperactivity disorder treatment and cardiovascular implications.

Hammerness PG, Surman CB, Chilton A.

Curr Psychiatry Rep. 2011 Oct;13(5):357-63. doi: 10.1007/s11920-011-0213-3. Review.

PMID:
21698412
[PubMed - indexed for MEDLINE]
11.

[Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guidelines. Part 2: a quantitative evaluation of long-acting medications].

Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E.

Z Kinder Jugendpsychiatr Psychother. 2008 Mar;36(2):97-106; quiz 106-7. doi: 10.1024/1422-4917.36.2.97. Review. German.

PMID:
18622939
[PubMed - indexed for MEDLINE]
12.

Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.

Wong IC, Asherson P, Bilbow A, Clifford S, Coghill D, DeSoysa R, Hollis C, McCarthy S, Murray M, Planner C, Potts L, Sayal K, Taylor E.

Health Technol Assess. 2009 Oct;13(50):iii-iv, ix-xi, 1-120. doi: 10.3310/hta13490.

PMID:
19883527
[PubMed - indexed for MEDLINE]
Free Article
13.

Pharmacotherapy of pediatric attention-deficit/hyperactivity disorder.

Vaughan B, Kratochvil CJ.

Child Adolesc Psychiatr Clin N Am. 2012 Oct;21(4):941-55. doi: 10.1016/j.chc.2012.07.005. Review.

PMID:
23040908
[PubMed - indexed for MEDLINE]
14.

Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database.

McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC.

Drug Saf. 2009;32(11):1089-96. doi: 10.2165/11317630-000000000-00000.

PMID:
19810780
[PubMed - indexed for MEDLINE]
15.

Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.

Peterson K, McDonagh MS, Fu R.

Psychopharmacology (Berl). 2008 Mar;197(1):1-11. Epub 2007 Nov 17. Review.

PMID:
18026719
[PubMed - indexed for MEDLINE]
16.

Sleep disturbances and ADHD medications.

Rostain AL.

Curr Psychiatry Rep. 2007 Oct;9(5):399-400. No abstract available.

PMID:
17915079
[PubMed - indexed for MEDLINE]
17.

[My child is so restless].

Schlamp D.

MMW Fortschr Med. 2007 Mar 8;149(10):39-40. Review. German.

PMID:
17408047
[PubMed - indexed for MEDLINE]
18.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
[PubMed - indexed for MEDLINE]
19.

Second opinions improve ADHD prescribing in a medicaid-insured community population.

Thompson JN, Varley CK, McClellan J, Hilt R, Lee T, Kwan AC, Lee T, Trupin E.

J Am Acad Child Adolesc Psychiatry. 2009 Jul;48(7):740-8. doi: 10.1097/CHI.0b013e3181a2b2ed.

PMID:
19465882
[PubMed - indexed for MEDLINE]
20.

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline.

Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E.

Eur Child Adolesc Psychiatry. 2006 Dec;15(8):476-95. Epub 2006 May 5. Review.

PMID:
16680409
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk